A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2006
08/22/2006	CA2207334C Sustained-release granular preparations and production process thereof
08/22/2006	CA2157836C L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
08/22/2006	CA2151396C Process for preparing controlled release pharmaceutical forms and the forms thus obtained
08/22/2006	CA2118792C Immunopotentiating and infection protective agent and production thereof
08/17/2006	WO2006086740A2 Cosmetic and cosmeceutical compositions for restoration of skin barrier function
08/17/2006	WO2006086654A2 Nanoformulations
08/17/2006	WO2006086428A2 Particles for inactivating toxins
08/17/2006	WO2006086330A2 Pharmaceutical compositions
08/17/2006	WO2006086107A2 Methods and compositions for minimizing accrual of inhalable insulin in the lungs
08/17/2006	WO2006086061A1 Stable tooth whitening gum with reactive ingredients
08/17/2006	WO2006086038A1 Methods and related compositions for reduction of fat and skin tightening
08/17/2006	WO2006085908A2 Devices and methods for measuring and enhancing drug or analyte transport to/from medical implant
08/17/2006	WO2006085874A1 Complex particles for delivery of materials to aquatic, marine, and other animals
08/17/2006	WO2006085856A1 Methods and dosage forms for reducing side effects of benzisozazole derivatives
08/17/2006	WO2006085747A1 Controlled release compositions for interferon based on pegt/pbt block copolymers
08/17/2006	WO2006085723A1 The enteric coated pharmaceutical oral formulations comprising acid-labile active substances, and a method thereof
08/17/2006	WO2006085666A1 Mixing apparatus
08/17/2006	WO2006085655A1 Ointment
08/17/2006	WO2006085627A1 Cream loaded with shellfish firing product powder and process for producing the same
08/17/2006	WO2006085607A1 Plant component-containing emulsion preparation and method for producing the same
08/17/2006	WO2006085583A1 Cell permeable peptide
08/17/2006	WO2006085521A1 Medicinal composition for transdermal absorption containing opipid receptor antagonist, method of producing the same and method of promoting the transdermal absorption of the antagonist
08/17/2006	WO2006085517A1 Ointment preparation or suppository for pdt based on chlorin or porphyrin derivative
08/17/2006	WO2006085497A1 Tablet disintegrating in the oral cavity
08/17/2006	WO2006085351A1 Contact lens, method for producing same, and pack for storage and maintenance of a contact lens
08/17/2006	WO2006085336A2 Stabilized anthracycline glycoside pharmaceutical compositions
08/17/2006	WO2006085335A2 Pharmaceutical composition of acid labile substances
08/17/2006	WO2006085315A2 System and method for categorizing activities in computer-accessible environments
08/17/2006	WO2006085299A2 Atomchip device
08/17/2006	WO2006085217A2 Solid adsorbates of hydrophobic drugs
08/17/2006	WO2006085168A2 Solid oral dosage forms of ziprasidone containing colloidal silicone dioxide
08/17/2006	WO2006085128A1 Cardiovascular therapeutic combinations
08/17/2006	WO2006085089A1 Solid dispersion of hydrophobic bioactive
08/17/2006	WO2006084998A1 Method for preparing pulverizable hemostatic compositions
08/17/2006	WO2006084914A2 Device for gastric treatment and manufacturing process for the same
08/17/2006	WO2006084696A1 Production of dosage forms comprising a solid dispersion of a microcrystalline agent
08/17/2006	WO2006084684A1 Pharmaceutical compositions comprising nebivolol and a hydrophilic polymer
08/17/2006	WO2006084547A1 Compositions containing biguanide
08/17/2006	WO2006084475A2 A tablet comprising a fibrate
08/17/2006	WO2006084382A1 Compositions and methods for multimodal imaging
08/17/2006	WO2006084339A1 Layered nanoparticles
08/17/2006	WO2006071601A3 Therapeutic compositions for intranasal administration of ketorolac
08/17/2006	WO2006068890A3 Lipid particles comprising bioactive agents, methods of preparing and uses thereof
08/17/2006	WO2006068759A3 Liposomes containing phytochemical agents and methods for making and using same
08/17/2006	WO2006060515A3 System for improved percutaneous absorption of skin benefiting agents
08/17/2006	WO2006058247A9 Dosage forms and methods of use thereof
08/17/2006	WO2006056144A3 Osmotic device containing licofelone
08/17/2006	WO2006054921A3 Anti-inflammatory extract and agent and method for the production thereof
08/17/2006	WO2006054315B1 Nonaqueous liquid parenteral aceclofenac formulation
08/17/2006	WO2006053646A3 Improvements in or relating to pharmaceutical compositions for local administration
08/17/2006	WO2006052254A3 Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby
08/17/2006	WO2006047362A9 Transdermal delivery systems
08/17/2006	WO2006046155A3 Loadable polyphosphazene-comprising particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
08/17/2006	WO2006041613A3 Nanoparticles for targeting hepatoma cells
08/17/2006	WO2006040779A3 Controlled release gastric floating matrix formulation containing imatinib
08/17/2006	WO2006024339A3 Controlled-release multilayer patch for the topical use
08/17/2006	WO2006023645A3 Aesthetic use of hyaluronan
08/17/2006	WO2005115343A3 Formulation obtained from a powder mixture comprising an inorganic pigment
08/17/2006	WO2005112977A3 Compositions for treatment with glucagon-like peptide, and methods of making and using the same
08/17/2006	WO2005111072A3 Notch-based fusion proteins and uses thereof
08/17/2006	WO2005107723A3 Transdermal delivery systems and transdermal chelation preparations
08/17/2006	WO2005097058A3 Cyclodextrin inclusions complexes of pyrimidine-2,4,6-triones
08/17/2006	WO2005084273A3 Method and apparatus for automatically modifying delivery profile of drug delivry system
08/17/2006	WO2005055988A3 Microparticles
08/17/2006	WO2005048923A3 Extended release venlafaxine formulation
08/17/2006	US20060184158 Osmotic delivery system with early zero order push power engine
08/17/2006	US20060184143 Implantable fluid delivery apparatuses and implantable electrode
08/17/2006	US20060183737 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists
08/17/2006	US20060183722 Formulation for lipophilic agents
08/17/2006	US20060183685 Peptide pharmaceutical formulations
08/17/2006	US20060183677 Novel exendin agonist formulations and methods of administration thereof
08/17/2006	US20060182997 Noble metal-magnetic metal oxide composite particle and method for producing same
08/17/2006	US20060182814 Biochemically balanced peritoneal dialysis solutions
08/17/2006	US20060182813 Colloidal silver composition having microbial properties
08/17/2006	US20060182810 Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
08/17/2006	US20060182809 System for transporting active substances in a biological system
08/17/2006	US20060182808 Antisolvent solidification process
08/17/2006	US20060182807 Copolymer and hemoprotein based novel compounds and uses thereof
08/17/2006	US20060182806 Extended-release propranolol composition
08/17/2006	US20060182805 Dosage form and method for sustained release of substituted pyrazine compound
08/17/2006	US20060182804 Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
08/17/2006	US20060182803 Oral sustained-release pharmaceutical composition of indapamide, production and use thereof
08/17/2006	US20060182802 Rapidly disintegrable solid preparation
08/17/2006	US20060182801 Sequestered antagonist formulations
08/17/2006	US20060182800 Novel pharmaceutical compositions for antihistaminic-decongestant combination and method of making such compositions
08/17/2006	US20060182799 Tabletting process
08/17/2006	US20060182798 Composition for gelatin coating, gelatin coating, and preparation using the same
08/17/2006	US20060182797 Sutained release formulation for venlafaxine hydrochloride
08/17/2006	US20060182796 Taste masked pharmaceutical compositions
08/17/2006	US20060182795 containing a polymer, a therapeutic agent, and a complexing agent, where the polymer interacts with the complexing agent in a host-guest or a guest-host interaction to form an inclusion complex; may be used to deliver a therapeutic agent in treatment of various disorders
08/17/2006	US20060182793 Cpg-packaged liposomes
08/17/2006	US20060182792 Liposome-forming compositions
08/17/2006	US20060182791 Transdermaltherapeutic system containing a pramipexol active agent
08/17/2006	US20060182786 Transmucosal form of administration with reduced mucosal irritation
08/17/2006	US20060182771 Formulations for ocular treatment
08/17/2006	US20060182770 aqueous solution of calcium chloride, magnesium chloride, potassium bromide; restoring skin barrier function to skin of a subject after a medical or a cosmetic procedure; adverse signs of aging of the skin, a dull complexion, skin or hair pigmentation disorders, skin dryness, acne vulgaris
08/17/2006	US20060182766 Stabilized protein compositions for topical administration and methods of making same
08/17/2006	US20060182753 Vaccines
08/17/2006	US20060182752 Tri-block polymers for nanosphere-based drug or gene delivery
08/17/2006	US20060182737 Wet wipes including a composition for reduction and prevention of wrinkles on the skin

1 ... 1586 1587 1588 1589 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 ... 2991